{"pmid":32115186,"title":"Outbreak of a new coronavirus: what anaesthetists should know.","text":["Outbreak of a new coronavirus: what anaesthetists should know.","Br J Anaesth","Peng, Philip W H","Ho, Pak-Leung","Hota, Susy S","32115186"],"journal":"Br J Anaesth","authors":["Peng, Philip W H","Ho, Pak-Leung","Hota, Susy S"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32115186","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.bja.2020.02.008","keywords":["2019-nCoV","COVID-19","MERS","SARS","airway management","coronavirus","infection prevention and control"],"source":"PubMed","topics":["General Info","Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1661359647578128385,"score":6.7365713,"similar":[{"pmid":32171952,"title":"The SARS-CoV-2 outbreak: what we know.","text":["The SARS-CoV-2 outbreak: what we know.","There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.","Int J Infect Dis","Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong","32171952"],"abstract":["There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus."],"journal":"Int J Infect Dis","authors":["Wu, Di","Wu, Tiantian","Liu, Qun","Yang, Zhicong"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32171952","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.ijid.2020.03.004","keywords":["Clinical features","CoVID-19","Diagnosis","Epidemiology","Managements strategies","SARS-CoV-2","Treatments","coronavirus"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission","Diagnosis","Treatment"],"weight":1,"_version_":1661518929210638336,"score":69.764656},{"pmid":32170865,"title":"Coronavirus Disease 2019 (COVID-19): What we know?","text":["Coronavirus Disease 2019 (COVID-19): What we know?","In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the World Health Organization respectively. The COVID-19 epidemic is spreading in China and all over the world now. The purpose of this review is primarily to review the pathogen, clinical features, diagnosis, and treatment of COVID-19, but also to comment briefly on the epidemiology and pathology based on the current evidences. This article is protected by copyright. All rights reserved.","J Med Virol","He, Feng","Deng, Yu","Li, Weina","32170865"],"abstract":["In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the World Health Organization respectively. The COVID-19 epidemic is spreading in China and all over the world now. The purpose of this review is primarily to review the pathogen, clinical features, diagnosis, and treatment of COVID-19, but also to comment briefly on the epidemiology and pathology based on the current evidences. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["He, Feng","Deng, Yu","Li, Weina"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170865","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25766","keywords":["COVID-19","SARS-CoV-2","coronavirus"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Diagnosis","Treatment"],"weight":1,"_version_":1661359647906332672,"score":67.1721},{"pmid":32105680,"title":"Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.","text":["Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know.","Coronavirus Disease 2019 (COVID-19) is an emerging disease with a rapid increase in cases and deaths since its first identification in Wuhan, China, in December 2019. Limited data are available about COVID-19 during pregnancy; however, information on illnesses associated with other highly pathogenic coronaviruses (i.e., severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS)) might provide insights into COVID-19's effects during pregnancy.","Am J Obstet Gynecol","Rasmussen, Sonja A","Smulian, John C","Lednicky, John A","Wen, Tony S","Jamieson, Denise J","32105680"],"abstract":["Coronavirus Disease 2019 (COVID-19) is an emerging disease with a rapid increase in cases and deaths since its first identification in Wuhan, China, in December 2019. Limited data are available about COVID-19 during pregnancy; however, information on illnesses associated with other highly pathogenic coronaviruses (i.e., severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS)) might provide insights into COVID-19's effects during pregnancy."],"journal":"Am J Obstet Gynecol","authors":["Rasmussen, Sonja A","Smulian, John C","Lednicky, John A","Wen, Tony S","Jamieson, Denise J"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32105680","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.ajog.2020.02.017","keywords":["-novel coronavirus","2019 nCoV","2019 novel coronavirus","2019-nCoV","MERS","Middle East Respiratory Syndrome","SARS","SARS-CoV-2","fetal death","fetus","maternal death","newborn","novel coronavirus","perinatal infection","pneumonia","pregnancy","preterm birth","sepsis","severe acute respiratory syndrome","vertical transmission"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Case Report"],"weight":1,"_version_":1661359647524651008,"score":63.926693},{"pmid":32104907,"title":"A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.","text":["A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.","In the past few decades, coronaviruses have risen as a global threat to public health. Currently, the outbreak of coronavirus disease-19 (COVID-19) from Wuhan caused a worldwide panic. There are no specific antiviral therapies for COVID-19. However, there are agents that were used during the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) epidemics. We could learn from SARS and MERS. Lopinavir (LPV) is an effective agent that inhibits the protease activity of coronavirus. In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with SARS and MERS, so that we might clarify the potential for the use of LPV in patients with COVID-19.","J Med Virol","Yao, Tian-Tian","Qian, Jian-Dan","Zhu, Wen-Yan","Wang, Yan","Wang, Gui-Qiang","32104907"],"abstract":["In the past few decades, coronaviruses have risen as a global threat to public health. Currently, the outbreak of coronavirus disease-19 (COVID-19) from Wuhan caused a worldwide panic. There are no specific antiviral therapies for COVID-19. However, there are agents that were used during the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) epidemics. We could learn from SARS and MERS. Lopinavir (LPV) is an effective agent that inhibits the protease activity of coronavirus. In this review, we discuss the literature on the efficacy of LPV in vitro and in vivo, especially in patients with SARS and MERS, so that we might clarify the potential for the use of LPV in patients with COVID-19."],"journal":"J Med Virol","authors":["Yao, Tian-Tian","Qian, Jian-Dan","Zhu, Wen-Yan","Wang, Yan","Wang, Gui-Qiang"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32104907","week":"20209|Feb 24 - Mar 01","doi":"10.1002/jmv.25729","keywords":["COVID-19","MERS","SARS","coronavirus","lopinavir"],"source":"PubMed","locations":["vivo","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1661359647544573952,"score":62.101368},{"pmid":32115733,"title":"Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","text":["Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children.","J Med Virol","Lu, Qi","Shi, Yuan","32115733"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cause china epidemics with high morbidity and mortality, the infection has been transmitted to other countries. About three neonates and more than 230 children cases are reported. The disease condition of the main children was mild. There is currently no evidence that SARS-CoV-2 can be transmitted transplacentally from mother to the newborn. The treatment strategy for children with Coronavirus disease (COVID-19) is based on adult experience. Thus far, no deaths have been reported in the pediatric age group. This review describes the current understanding of COVID-19 infection in newborns and children."],"journal":"J Med Virol","authors":["Lu, Qi","Shi, Yuan"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32115733","week":"202010|Mar 02 - Mar 08","doi":"10.1002/jmv.25740","source":"PubMed","locations":["china"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info","Treatment","Transmission","Mechanism","Diagnosis"],"weight":1,"_version_":1661359647600148480,"score":61.240604}]}